https://stock.noler.com/us/stock/bioscience-neutraceuticals-inc https://stock.noler.com/us/stock/bioscience-neutraceuticals-inc/accounts-payable https://stock.noler.com/us/stock/bioscience-neutraceuticals-inc/accounts-payable-and-accrued-liabilities-current https://stock.noler.com/us/stock/bioscience-neutraceuticals-inc/accounts-payable-and-accrued-liabilities-noncurrent https://stock.noler.com/us/stock/bioscience-neutraceuticals-inc/accounts-payable-interest-bearing-interest-rate https://stock.noler.com/us/stock/bioscience-neutraceuticals-inc/accrued-liabilities-current https://stock.noler.com/us/stock/bioscience-neutraceuticals-inc/accrued-liabilities-current-and-noncurrent https://stock.noler.com/us/stock/bioscience-neutraceuticals-inc/additional-paid-in-capital https://stock.noler.com/us/stock/bioscience-neutraceuticals-inc/amortization-of-debt-discount-premium https://stock.noler.com/us/stock/bioscience-neutraceuticals-inc/assets-of-disposal-group-including-discontinued-operation https://stock.noler.com/us/stock/bioscience-neutraceuticals-inc/basic-shares https://stock.noler.com/us/stock/bioscience-neutraceuticals-inc/capital-expenditure-discontinued-operations https://stock.noler.com/us/stock/bioscience-neutraceuticals-inc/cash https://stock.noler.com/us/stock/bioscience-neutraceuticals-inc/cash-and-equivalents https://stock.noler.com/us/stock/bioscience-neutraceuticals-inc/cash-flow-breakdown https://stock.noler.com/us/stock/bioscience-neutraceuticals-inc/common-stock-par-or-stated-value-per-share https://stock.noler.com/us/stock/bioscience-neutraceuticals-inc/common-stock-value https://stock.noler.com/us/stock/bioscience-neutraceuticals-inc/conversion-of-stock-amount-issued https://stock.noler.com/us/stock/bioscience-neutraceuticals-inc/conversion-of-stock-shares-converted https://stock.noler.com/us/stock/bioscience-neutraceuticals-inc/convertible-debt https://stock.noler.com/us/stock/bioscience-neutraceuticals-inc/convertible-long-term-notes-payable https://stock.noler.com/us/stock/bioscience-neutraceuticals-inc/convertible-notes-payable-current https://stock.noler.com/us/stock/bioscience-neutraceuticals-inc/cost-of-goods-sold https://stock.noler.com/us/stock/bioscience-neutraceuticals-inc/cost-of-revenue https://stock.noler.com/us/stock/bioscience-neutraceuticals-inc/cover-page-shares-outstanding https://stock.noler.com/us/stock/bioscience-neutraceuticals-inc/current-assets https://stock.noler.com/us/stock/bioscience-neutraceuticals-inc/current-income-tax-expense-benefit https://stock.noler.com/us/stock/bioscience-neutraceuticals-inc/current-liabilities https://stock.noler.com/us/stock/bioscience-neutraceuticals-inc/current-portion-of-long-term-debt https://stock.noler.com/us/stock/bioscience-neutraceuticals-inc/debt-conversion-converted-instrument-amount https://stock.noler.com/us/stock/bioscience-neutraceuticals-inc/debt-convertible-beneficial-conversion-feature https://stock.noler.com/us/stock/bioscience-neutraceuticals-inc/debt-decrease-forgiveness https://stock.noler.com/us/stock/bioscience-neutraceuticals-inc/debt-increase-accrued-interest https://stock.noler.com/us/stock/bioscience-neutraceuticals-inc/deferred-offering-costs https://stock.noler.com/us/stock/bioscience-neutraceuticals-inc/deferred-tax-assets-net https://stock.noler.com/us/stock/bioscience-neutraceuticals-inc/deferred-tax-assets-operating-loss-carryforwards https://stock.noler.com/us/stock/bioscience-neutraceuticals-inc/deferred-tax-assets-valuation-allowance https://stock.noler.com/us/stock/bioscience-neutraceuticals-inc/development-stage-enterprise-deficit-accumulated-during-development-stage https://stock.noler.com/us/stock/bioscience-neutraceuticals-inc/discontinued-operation-amount-of-adjustment-to-prior-period-gain-loss-on-disposal-before-income-tax https://stock.noler.com/us/stock/bioscience-neutraceuticals-inc/discontinued-operation-income-loss-from-discontinued-operation-before-income-tax https://stock.noler.com/us/stock/bioscience-neutraceuticals-inc/disposal-group-not-discontinued-operation-gain-loss-on-disposal https://stock.noler.com/us/stock/bioscience-neutraceuticals-inc/dividends-share-based-compensation-stock https://stock.noler.com/us/stock/bioscience-neutraceuticals-inc/due-to-related-parties-current https://stock.noler.com/us/stock/bioscience-neutraceuticals-inc/earnings-per-share-basic-and-diluted https://stock.noler.com/us/stock/bioscience-neutraceuticals-inc/financing-cash-flow https://stock.noler.com/us/stock/bioscience-neutraceuticals-inc/gain-loss-on-disposition-of-assets https://stock.noler.com/us/stock/bioscience-neutraceuticals-inc/general-and-administrative-expense https://stock.noler.com/us/stock/bioscience-neutraceuticals-inc/goodwill https://stock.noler.com/us/stock/bioscience-neutraceuticals-inc/goodwill-impairment-loss https://stock.noler.com/us/stock/bioscience-neutraceuticals-inc/goodwill-other-increase-decrease https://stock.noler.com/us/stock/bioscience-neutraceuticals-inc/gross-profit https://stock.noler.com/us/stock/bioscience-neutraceuticals-inc/income-loss-from https://stock.noler.com/us/stock/bioscience-neutraceuticals-inc/income-loss-from-discontinued-operations-net-of-tax https://stock.noler.com/us/stock/bioscience-neutraceuticals-inc/income-tax https://stock.noler.com/us/stock/bioscience-neutraceuticals-inc/income-tax-at-federal-statutory-rate https://stock.noler.com/us/stock/bioscience-neutraceuticals-inc/income-taxes-paid https://stock.noler.com/us/stock/bioscience-neutraceuticals-inc/increase-decrease-in-accounts-payable https://stock.noler.com/us/stock/bioscience-neutraceuticals-inc/increase-decrease-in-accounts-payable-and-accrued-liabilities https://stock.noler.com/us/stock/bioscience-neutraceuticals-inc/increase-decrease-in-accrued-liabilities https://stock.noler.com/us/stock/bioscience-neutraceuticals-inc/increase-decrease-in-deferred-charges https://stock.noler.com/us/stock/bioscience-neutraceuticals-inc/increase-decrease-in-interest-payable-net https://stock.noler.com/us/stock/bioscience-neutraceuticals-inc/increase-decrease-in-inventories https://stock.noler.com/us/stock/bioscience-neutraceuticals-inc/increase-decrease-in-prepaid-expense https://stock.noler.com/us/stock/bioscience-neutraceuticals-inc/interest-expense https://stock.noler.com/us/stock/bioscience-neutraceuticals-inc/interest-expense-on-debt https://stock.noler.com/us/stock/bioscience-neutraceuticals-inc/interest-expense-other https://stock.noler.com/us/stock/bioscience-neutraceuticals-inc/interest-income-expense-net https://stock.noler.com/us/stock/bioscience-neutraceuticals-inc/interest-paid https://stock.noler.com/us/stock/bioscience-neutraceuticals-inc/interest-payable-current https://stock.noler.com/us/stock/bioscience-neutraceuticals-inc/interest-payable-current-and-noncurrent https://stock.noler.com/us/stock/bioscience-neutraceuticals-inc/inventory https://stock.noler.com/us/stock/bioscience-neutraceuticals-inc/investing-cash-flow https://stock.noler.com/us/stock/bioscience-neutraceuticals-inc/long-term-notes-payable https://stock.noler.com/us/stock/bioscience-neutraceuticals-inc/net-cash-from-financing-activities https://stock.noler.com/us/stock/bioscience-neutraceuticals-inc/net-cash-from-operating-activities https://stock.noler.com/us/stock/bioscience-neutraceuticals-inc/net-change-in-cash https://stock.noler.com/us/stock/bioscience-neutraceuticals-inc/net-income https://stock.noler.com/us/stock/bioscience-neutraceuticals-inc/notes-payable-current https://stock.noler.com/us/stock/bioscience-neutraceuticals-inc/operating-cash-flow https://stock.noler.com/us/stock/bioscience-neutraceuticals-inc/operating-expenses https://stock.noler.com/us/stock/bioscience-neutraceuticals-inc/operating-income https://stock.noler.com/us/stock/bioscience-neutraceuticals-inc/operating-loss-carryforwards https://stock.noler.com/us/stock/bioscience-neutraceuticals-inc/other-general-expense https://stock.noler.com/us/stock/bioscience-neutraceuticals-inc/other-noncash-income-expense https://stock.noler.com/us/stock/bioscience-neutraceuticals-inc/other-nonoperating-income-expense https://stock.noler.com/us/stock/bioscience-neutraceuticals-inc/paid-in-capital-shares-issued-issuance-costs https://stock.noler.com/us/stock/bioscience-neutraceuticals-inc/payments-for-advance-to-affiliate https://stock.noler.com/us/stock/bioscience-neutraceuticals-inc/payments-to-acquire-interest-in-subsidiaries-and-affiliates https://stock.noler.com/us/stock/bioscience-neutraceuticals-inc/preferred-shares-facts https://stock.noler.com/us/stock/bioscience-neutraceuticals-inc/preferred-stock-par-or-stated-value-per-share https://stock.noler.com/us/stock/bioscience-neutraceuticals-inc/preferred-stock-shares-authorized https://stock.noler.com/us/stock/bioscience-neutraceuticals-inc/preferred-stock-shares-issued https://stock.noler.com/us/stock/bioscience-neutraceuticals-inc/preferred-stock-shares-outstanding https://stock.noler.com/us/stock/bioscience-neutraceuticals-inc/prepaid-expense-and-other-assets https://stock.noler.com/us/stock/bioscience-neutraceuticals-inc/prepaid-expense-current https://stock.noler.com/us/stock/bioscience-neutraceuticals-inc/pretax-income https://stock.noler.com/us/stock/bioscience-neutraceuticals-inc/proceeds-from-convertible-debt https://stock.noler.com/us/stock/bioscience-neutraceuticals-inc/proceeds-from-issuance-or-sale-of-equity https://stock.noler.com/us/stock/bioscience-neutraceuticals-inc/proceeds-from-notes-payable https://stock.noler.com/us/stock/bioscience-neutraceuticals-inc/proceeds-from-related-party-debt https://stock.noler.com/us/stock/bioscience-neutraceuticals-inc/proceeds-from-repayments-of-related-party-debt https://stock.noler.com/us/stock/bioscience-neutraceuticals-inc/professional-fees https://stock.noler.com/us/stock/bioscience-neutraceuticals-inc/profit-loss https://stock.noler.com/us/stock/bioscience-neutraceuticals-inc/public-float https://stock.noler.com/us/stock/bioscience-neutraceuticals-inc/repayments-of-debt https://stock.noler.com/us/stock/bioscience-neutraceuticals-inc/repayments-of-related-party-debt https://stock.noler.com/us/stock/bioscience-neutraceuticals-inc/repayments-of-short-term-debt https://stock.noler.com/us/stock/bioscience-neutraceuticals-inc/retained-earnings https://stock.noler.com/us/stock/bioscience-neutraceuticals-inc/revenue https://stock.noler.com/us/stock/bioscience-neutraceuticals-inc/sale-of-stock-price-per-share https://stock.noler.com/us/stock/bioscience-neutraceuticals-inc/selling-and-marketing-expense https://stock.noler.com/us/stock/bioscience-neutraceuticals-inc/shareholders-equity https://stock.noler.com/us/stock/bioscience-neutraceuticals-inc/shares-authorized https://stock.noler.com/us/stock/bioscience-neutraceuticals-inc/shares-issued https://stock.noler.com/us/stock/bioscience-neutraceuticals-inc/stock-based-compensation https://stock.noler.com/us/stock/bioscience-neutraceuticals-inc/stock-issued-new-shares-sold https://stock.noler.com/us/stock/bioscience-neutraceuticals-inc/stock-issued-shares-issued-shares-issued-for-services https://stock.noler.com/us/stock/bioscience-neutraceuticals-inc/stock-issued-shares-issued-shares-new-issues https://stock.noler.com/us/stock/bioscience-neutraceuticals-inc/stock-issued-shares-issued-value-conversion-of-convertible-securities https://stock.noler.com/us/stock/bioscience-neutraceuticals-inc/stock-issued-shares-issued-value-issued-for-cash https://stock.noler.com/us/stock/bioscience-neutraceuticals-inc/stock-issued-shares-issued-value-issued-for-services https://stock.noler.com/us/stock/bioscience-neutraceuticals-inc/tax-rate-reconciliation-at-federal-statutory-income-tax-rate https://stock.noler.com/us/stock/bioscience-neutraceuticals-inc/tax-reconciliation-change-in-deferred-tax-assets-valuation-allowance https://stock.noler.com/us/stock/bioscience-neutraceuticals-inc/total-assets https://stock.noler.com/us/stock/bioscience-neutraceuticals-inc/total-liabilities https://stock.noler.com/us/stock/bioscience-neutraceuticals-inc/total-liabilities-and-equity https://stock.noler.com/us/stock/bioscience-neutraceuticals-inc/total-long-term-debt https://stock.noler.com/us/stock/bioscience-neutraceuticals-inc/weighted-average-number-of-share-outstanding-basic-and-diluted